Supplementary Online Content
|
|
- Geraldine Lambert
- 5 years ago
- Views:
Transcription
1 Supplementary Online Content Anagnostou E, Aman MG, Handen BL, et al. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autistic spectrum disorder: a randomized clinical trial. JAMA Psychiatry. Published online August 24, doi: /jamapsychiatry etable 1. Effect of Metformin vs Placebo on Metabolic Parameters, ABC Subscales, and CGI Improvement etable 2. BMI Shift Table etable 3. Baseline Variables (Continuous) etable 4. Psychotropic Medications Used at Baseline etable 5. Unadjusted Summary Statistics Among All Participants Who Initiated Treatment etable 6. Site-Specific Effects of Metformin on 16-Week Changes in BMI z Scores etable 7. ITT Analysis: Effect of Metformin vs Placebo on Anthropometric Measurements, Metabolic Parameters, Behavioral Measures, and Clinical Global Impression efigure. Change in BMI vs Baseline BMI Scatterplot of 16-wk Change in BMI z Score vs Baseline BMI z Score This supplementary material has been provided by the authors to give readers additional information about their work American Medical Association. All rights reserved. 1
2 Change in BMI vs. baseline BMI ( and )] Error! Bookmark not defined. etable 1. Effect of Metformin vs Placebo on Metabolic Parameters, ABC Subscales, and CGI Improvement week Chan ge Metformin (n = 28) Placebo (n = 32) Treatment Difference 95% CI p 16- week Change 95% CI p 16- week change 95% CI Total cholesterol (mg/dl) (-8.76,6.67) (-10.33,3.75) (-8.17,12.66) LDL (mg/dl) (-10.47,1.64) (-6.11,5.29) (-12.29,4.29) HDL (mg/dl) 3.27 (-1.41,7.94) (-5.26,3.29) (-2.04,10.54) Triglycerides (mg/dl) 5.74 (-22.34,33.81) (-19.62,31.98) ( ,36.09) Glucose, fasting (mg/dl) (-6.68,0.56) (-5.76,0.94) (-5.18,3.88) Insulin, fasting (µiu/ml) 1.97 (-10.44,14.38) (-8.44,14.35) ( ,15.85) HOMA-IR (-2.385,3.441) (-2.074,3.261) ( ,3.855) Hgb A1C (%) (-0.143,0.035) (-0.047,0.114) ( ,0.032) ABC Lethargy (-4.80,0.63) (-3.64,1.52) (-4.54,2.50) ABC Stereotypy (-1.54,0.85) (-2.30,-0.03) (-0.72,2.36) ABC Hyperactivity (-3.79,1.50) (-4.10,0.89) (-3.09,4.00) ABC Inappropriate Speech (-1.37,0.03) (-0.77,0.55) (-1.50,0.38) CGI Improvement (-0.42,0.14) (-0.33,0.21) (-0.47,0.31) Effect Size p 1 Results were obtained from linear contrasts of estimates from the shared-baseline, linear mixed model described in the Methods American Medical Association. All rights reserved. 2
3 etable 2. BMI Shift Table Initial BMI Category Metformin Week 16 BMI Category Placebo 1. Normal 2. Overweight 3. Obese 1. Normal 2. Overweight 3. Obese 1. Normal Overweight Obese Cross tabulation of baseline and week 16 BMI status Normal = 15th to <85th percentile, Overweight = 85th to <95th percentile, Obese = 95 t th percentile 2016 American Medical Association. All rights reserved. 3
4 etable 3. Baseline Variables (Continuous) O Difference of means Metformin Placebo 95% CI Variable Mean SD Min Max Mean SD Min Max Diff Lower Upper p age Height z- score Weight z- score BMI z-score weight BMI Weight percentile BMI percentile Waist to hip ratio IQ CGI severity Total cholesterol (mg/dl) LDL (mg/dl) HDL (mg/dl) American Medical Association. All rights reserved. 4
5 Difference of means Metformin Placebo 95% CI Variable Mean SD Min Max Mean SD Min Max Diff Lower Upper p Triglycerides (mg/dl) Glucose (mg/dl) Insulin (μiu/ml) HOMA_IR HgbA1C (%) Please note that conversion factors to SI units for all variables are shown on next page 2016 American Medical Association. All rights reserved. 5
6 etable 3 (continued). SI/Conventional unit conversion factors Analyte Conventional Unit Conversion Factor 1 SI Unit Cholesterol (total) mg/dl mmol/l Cholesterol, low-density (LDL) mg/dl mmol/l Cholesterol, high-density (HDL) mg/dl mmol/l Triglycerides mg/dl mmol/l Glucose mg/dl mmol/l Insulin μiu/ml pmol/l Hemoglobin A1c % of total hemoglobin 0.01 Proportion of total hemoglobin 1 Multiply value in convention units by stated conversion factor to yield the same value in SI units American Medical Association. All rights reserved. 6
7 etable 4. Psychotropic Medications Used at Baseline Medication Percentage using at baseline Metformin Placebo N % N % Alpha 2-Adrenergic Agonists 9 32% 10 31% Antidepressants 15 54% 17 53% Antipsychotics % % Benzodiazepines 1 4% 4 13% Beta Blockers 0 0% 0 0% CNS stimulants 6 21% 10 31% Mood stabilizers 2 7% 3 9% Norepinephrine re-uptake inhibitor 1 4% 3 9% 2016 American Medical Association. All rights reserved. 7
8 etable 5. Unadjusted Summary Statistics Among All Participants Who Initiated Treatment Metformin (n=28) Placebo (n=32) Baseline Final Visit Delta Baseline Final Visit Delta N Mean SD N Mean SD N Mean SD N Mean SD N Mean SD N Mean SD Measure Study Week BMI z-score Weight z-score BMI (kg/m 2 ) Weight (kg) BMI percentile (%) Weight percentile (%) Waist-hip ratio (%) Total cholesterol (mg/dl) LDL (mg/dl) HDL (mg/dl) Triglycerides (mg/dl) Glucose, fasting (mg/dl) Insulin, fasting (µiu/ml) HOMA-IR Hgb A1C (%) American Medical Association. All rights reserved. 8
9 etable 6. Site-Specific Effects of Metformin on 16-Week Changes in BMI z Scores Treatment Difference 16-week change 95% CI Effect size P 1 Vanderbilt University (-0.267,-0.009) University of Pittsburgh (-0.233,-0.003) Holland Bloorview Rehabilitation Hospital (-0.184,0.035) Nationwide Children s Hospital (-0.189,0.036) DF site x treatment interaction p = American Medical Association. All rights reserved. 9
10 etable 7. ITT Analysis: Effect of Metformin vs Placebo on Anthropometric Measurements, Metabolic Parameters, Behavioral Measures, and Clinical Global Impression 1 Metformin (n = 29) Placebo (n = 32) Treatment Difference 16-week 16-week 16-week Effect 95% CI p 95% CI p 95% CI Change Change change Size p BMI z-score (-0.125,-0.035) < (-0.026,0.059) (-0.158,-0.035) Weight z-score (-0.150,-0.048) < (-0.013,0.084) (-0.204,-0.064) <.001 BMI raw (kg/m 2 ) (-0.792,-0.061) (0.177,0.870) (-1.454,-0.447) <.001 Weight raw (kg) (-0.882,1.010) (1.904,3.698) < (-4.040,-1.434) <.001 BMI percentile (%) (-1.448,-0.203) (-0.564,0.631) (-1.653,-0.065) Weight percentile (%) (-1.885,-0.324) (-0.432,1.057) (-2.490,-0.343) Waist-hip ratio (%) (-1.053,1.589) (-0.783,1.746) (-1.883,1.455) Total cholesterol (mg/dl) (-8.80,6.63) (-10.36,3.72) (-8.17,12.64) LDL (mg/dl) (-10.50,1.61) (-6.16,5.24) (-12.27,4.29) HDL (mg/dl) 3.24 (-1.44,7.91) (-5.29,3.25) (-2.03,10.54) Triglycerides (mg/dl) 6.17 (-21.86,34.21) (-19.06,32.48) (-37.04,35.98) Glucose, fasting (mg/dl) (-6.75,0.48) (-5.85,0.84) (-5.16,3.90) Insulin, fasting (μiu/ml) 2.01 (-10.40,14.41) (-8.41,14.38) (-17.80,15.85) HOMA-IR 0.54 (-2.37,3.45) (-2.06,3.27) (-3.98,3.86) Hgb A1C (%) (-0.143,0.035) (-0.047,0.114) (-0.207,0.032) ABC Irritability (-3.23,1.12) (-3.09,1.07) (-3.00,2.90) ABC Lethargy (-4.03,1.48) (-4.05,1.25) (-3.56,3.81) ABC Stereotypy (-1.43,0.91) (-2.33,-0.08) (-0.57,2.47) ABC Hyperactivity (-3.67,1.49) (-4.13,0.81) (-2.92,4.06) ABC Inappropriate (-1.44,-0.06) (-0.78,0.54) (-1.57,0.31) Speech CGI Improvement (-0.41,0.14) (-0.32,0.20) (-0.46,0.30) Results were obtained from linear contrasts of estimates from the shared-baseline, linear mixed model described in the Methods American Medical Association. All rights reserved. 10
11 efigure. Change in BMI vs Baseline BMI Scatterplot of 16-wk Change in BMI z-score vs Baseline BMI z Score BMI z score change Baseline BMI z score 2016 American Medical Association. All rights reserved. 11
Supplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationJean Paul Richter, writer ( )
The words a father speaks to his children in the privacy of the home are not overheard at the time, but, as in whispering galleries, they will be clearly heard at the end and by posterity. Jean Paul Richter,
More informationSupplementary Online Content
Supplementary Online Content Afkarian M, Zelnick L, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. doi:10.1001/jama.2016.10924 emethods efigure
More informationSupplementary Online Content
Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.
More informationSupplementary Online Content
Supplementary Online Content Engebretson SP, Hyman LG, Michalowicz BS, et al. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels among persons with type 2 diabetes and chronic periodontitis:
More informationMore than We Bargained For: Metabolic Side Effects of Antipsychotic Medications
More than We Bargained For: Metabolic Side Effects of Antipsychotic Medications Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Disclosure In the past 12 months I have received
More informationSYNOPSIS OF RESEARCH REPORT (PROTOCOL BC20779)
TITLE OF THE STUDY / REPORT No. / DATE OF REPORT INVESTIGATORS / CENTERS AND COUNTRIES Clinical Study Report Protocol BC20779: Multicenter, double-blind, randomized, placebo-controlled, dose ranging phase
More informationAlpha-2 Agonists. Antipsychotics
Table 5: Randomized Controlled Trials of Psychotropic Medications in Children and Adolescents with ASD Agent Study Target Symptoms Dose Demographics Significant Side Clonidine Guanfacine Jaselskis et al.,
More informationSupplementary Online Content
Supplementary Online Content Sigal RJ, Alberga AS, Goldfield GS, et al. Effects of aerobic training, resistance training, or both on percentage body fat and cardiometabolic risk markers in obese adolescents:
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationDiagnostic Test of Fat Location Indices and BMI for Detecting Markers of Metabolic Syndrome in Children
Diagnostic Test of Fat Location Indices and BMI for Detecting Markers of Metabolic Syndrome in Children Adegboye ARA; Andersen LB; Froberg K; Heitmann BL Postdoctoral researcher, Copenhagen, Denmark Research
More informationThe role of physical activity in the prevention and management of hypertension and obesity
The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity
More informationSupplementary Online Content
Supplementary Online Content Ebbing M, Bønaa KH, Nygård O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B 1. JAMA. 9;3(19):119-1. etable 1. Circulating Levels of B
More informationCardiometabolic Side Effects of Risperidone in Children with Autism
Cardiometabolic Side Effects of Risperidone in Children with Autism Susan J. Boorin, MSN, PMHNP-BC PhD Candidate Yale School of Nursing 1 This speaker has no conflicts of interest to disclose. 2 Boorin
More informationSupplementary Online Content
Supplementary Online Content McEvoy JW, Chen Y, Ndumele CE, et al. Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol.
More informationSupplementary Online Content
Supplementary Online Content Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in cardiology practices
More informationCardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study
Research Original Investigation Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study Christoph U. Correll, MD; Delbert G. Robinson,
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationSupplementary Online Content
Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.
More informationSupplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and
1 Supplementary Online Content 2 3 4 5 6 Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on sympton burden and severity in patients with atrial
More informationSupplementary Online Content
Supplementary Online Content Daly EJ, Singh JB, Fedgchin M, et al. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized
More informationTable S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group
Table S1: Nutrient composition of cracker and almond snacks Cracker* Almond** Weight, g 77.5 g (5 sheets) 56.7 g (2 oz.) Energy, kcal 338 364 Carbohydrate, g (kcal) 62.5 12.6 Dietary fiber, g 2.5 8.1 Protein,
More informationSYNOPSIS 2/198 CSR_BDY-EFC5825-EN-E02. Name of company: TABULAR FORMAT (For National Authority Use only)
SYNOPSIS Title of the study: A randomized, double-blind, placebo-controlled, parallel-group, fixed-dose (rimonabant 20 mg) multicenter study of long-term glycemic control with rimonabant in treatment-naïve
More informationShould Psychiatrists be diagnosing (and treating) metabolic syndrome
Should Psychiatrists be diagnosing (and treating) metabolic syndrome David Hopkins Clinical Director, Diabetes King s College Hospital, London Diabetes prevalence (thousands) Diabetes in the UK: 1995-2010
More informationDirector, Employee Health & Productivity. Coordinator, Employee Health & Productivity
Director, Employee Health & Productivity Coordinator, Employee Health & Productivity Table 2:. ChartE: Female HDL Cholesterol Risk Levels Optimal Borderline High Risk 80% 60% 40% 20% 0% LDL Cholesterol
More informationRole of ADHD medication in children with autism spectrum disorder. Pieter Hoekstra University of Groningen, Netherlands
Role of ADHD medication in children with autism spectrum disorder Pieter Hoekstra University of Groningen, Netherlands Symptoms of ADHD are highly prevalent in children with ASD Two independent chart reviews
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationSupplementary Online Content
Supplementary Online Content Huybrechts KF, Hernández-Díaz S, Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. Published online August 17, 2016.
More informationEnergy Balance Equation
Energy Balance Equation Intake Expenditure Hunger Satiety Nutrient Absorption Metabolic Rate Thermogenesis Activity Eat to Live! Live to Eat! EAT TO LIVE Intake = Expenditure Weight Stable LIVE TO EAT
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationSupplementary Table 1. Patient demographics and baseline characteristics (treated patients).
Supplementary Table 1. Patient demographics and baseline characteristics (treated patients). Placebo (n=188) 10 mg (n=186) 25 mg (n=189) Total (n=563) Gender, n (%) Male 75 (40) 97 (52) 84 (44) 256 (45)
More informationIntegrated Health/Person Centered Health Home Austin Travis County Integral Care
Integrated Health/Person Centered Health Home Austin Travis County Integral Care Kathleen A. Casey Dawn R. Handley June 20, 2014 Influencing factors Strong track record of successful integration with FQHC
More informationSupplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More information2017 Employee Wellness Health Assessment Report
Employee Wellness National Consortium for Building Healthy Academic Communities (BHAC) Healthier Tennessee Workplace 2017 Employee Wellness Health Assessment Report Blood Pressure 2017 (387 total) (National
More informationLEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME
LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman
More informationSupplementary Online Content
Supplementary Online Content Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Int Med. Published online February
More informationComprehensive Screening Detects Undiagnosed Autoimmunity In Adult-onset Type 2 Diabetes
Comprehensive Screening Detects Undiagnosed Autoimmunity In Adult-onset Type 2 Diabetes SRINIVASA R. NAGALLA, MD, PATURI V. RAO, MD, CARYN K. SNYDER, MPH, JERRY P. PALMER, MD, CHARLES T. ROBERTS, PhD DiabetOmics,
More informationSupplementary Online Content
Supplementary Online Content Sussman JB, Kerr EA, Saini SD, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery
More informationCARE PATHWAYS. Allyson Ashley
CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The
More informationSYNOPSIS INDIVIDUAL STUDY TABLE REFERRING TO PART OF THE DOSSIER (FOR NATIONAL AUTHORITY USE ONLY) Volume: Page:
SYNOPSIS Risperdal Risperidone (R064766) Protocol No.: RIS-USA-150 Part 1 INDIVIDUAL STUDY TABLE REFERRING TO PART OF THE DOSSIER AUTHORITY USE ONLY) Title of Study: A Double-Blind, Placebo-Controlled
More informationSupplementary Online Content
Supplementary Online Content Viktorin A, Uher R, Kolevzon A, Reichenberg A, Levine SZ, Sandin S. Association of antidepressant medication use during pregnancy with intellectual disability in offspring.
More informationSupplementary Online Content
Supplementary Online Content Basaria S, Harman SM, Travison TG, et al. The effects of testosterone administration for three years on subclinical atherosclerosis progression in older men with low or low
More informationObesity and Insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea
https://doi.org/10.7180/kmj.2016.31.2.157 KMJ Original Article Obesity and Insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea Ju Won Lee, Nam Kyu Kim, Hyun Joon Park,
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationPhysical Health Management: Why it s important for adolescents and young adults in mental health services
Physical Health Management: Why it s important for adolescents and young adults in mental health services Early Intervention Service Wellington Lauren Heath and Erin Dawson Introduction Second generation
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationOBESITY IN PRIMARY CARE
OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading
More informationSupplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups
Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate
More informationSupplementary Online Content
Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic
More informationSupplementary Online Content
Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA
More informationKaren Olson, 1 Bryan Hendricks, 2 and David K. Murdock Introduction. 2. Methods
Cholesterol Volume 2012, Article ID 794252, 4 pages doi:10.1155/2012/794252 Research Article The Triglyceride to HDL Ratio and Its Relationship to Insulin Resistance in Pre- and Postpubertal Children:
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationClient Report Screening Program Results For: Missouri Western State University October 28, 2013
Client Report For: Missouri Western State University October 28, 2013 Executive Summary PROGRAM OVERVIEW From 1/1/2013-9/30/2013, Missouri Western State University participants participated in a screening
More informationHealth benefits of mango supplementation as it relates to weight loss, body composition, and inflammation: a pilot study
Title of Study: Health benefits of mango supplementation as it relates to weight loss, body composition, and inflammation: a pilot study Principal Investigator: Dr. Edralin A. Lucas Nutritional Sciences
More informationPopulation: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F80VNUM. Sas Label: Categories:
Form - Last Update: 04/6/001 umber of Obs: 161771 Participant ID 1 ID Participant ID F Days since randomization/enrollment 161771-886 8-59451 516548 FDAYS F Days since randomization/enrollment F Visit
More informationSupplementary Online Content
Supplementary Online Content Hales CM, Fryar CD, Carroll MD, Freedman DS, Aoki Y, Ogden CL. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United
More informationImplications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
More informationSupplementary Online Content
Supplementary Online Content Hayes J, Jackson JL, McNutt GM, Hertz BJ, Ryan JJ, Pawlikowski SA. Association between physician time-unlimited vs time-limited internal medicine board certification and ambulatory
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More informationKelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009
Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationUNDERSTANDING AND MANAGING METABOLIC SYNDROME IN PSYCHIATRY Dr Sanil Rege MBBS, MRCPsych, FRANZCP Consultation-Liaison Psychiatry PaRK MHS, Western
UNDERSTANDING AND MANAGING METABOLIC SYNDROME IN PSYCHIATRY Dr Sanil Rege MBBS, MRCPsych, FRANZCP Consultation-Liaison Psychiatry PaRK MHS, Western Australia Talks Facilitator of the CTF Exam Prep Course
More informationObesity: from epidemiology to treatment Entwicklung der Adipositas und Epidemiology, definition and des Diabetes in Europa diagnosis of obesities
Obesity: from epidemiology to treatment Entwicklung der Adipositas und Epidemiology, definition and des Diabetes in Europa diagnosis of obesities Hermann Toplak, Präsident ÖDG &EASO Hermann Toplak, President
More informationInsulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults
Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults Ochoa JE 1, Correa M 2, Valencia AM 2, Gallo J 2, McEwen
More informationGATEWAY Trial. Bariatric Surgery versus Conventional Medical Treatment in Obese Patients with Hypertension
GATEWAY Trial Bariatric Surgery versus Conventional Medical Treatment in Obese Patients with Hypertension Carlos Aurelio Schiavon, MD, FACS On behalf of the GATEWAY Executive Committee and Investigators
More informationWAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS?
WAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS? Consuelo L. Orense, MSPH, Charmaine A. Duante, RMT, MS Epid.(PH), Ermelita N. Bautista, MPH and Lilibeth P. Dasco, MSAN ABSTRACT The study aimed
More informationMETABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2012 vol. 116, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Ana-Maria Pelin 1, Silvia Mǎtǎsaru 2 University
More informationADHD in the Preschool Aged Child
ADHD in the Preschool Aged Child (PATS) 11/2/2013 Stephen Meister MD, MHA, FAAP The Edmund N Ervin Pediatric Center (PATS) National Institute of Mental Health study First papers published in 2006 after
More informationSupplementary Online Content
Supplementary Online Content Clark WF, Sontrop JM, Huang S-H et al. Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: the CKD WIT Randomized
More information(Professor, Department of Applied Nutrition and Food Technology, Islamic University, Kushtia, Bangladesh.) 3
IOSR Journal of Nursing and Health Science (IOSR-JNHS) e- ISSN: 2320 1959.p- ISSN: 2320 1940 Volume 7, Issue 4 Ver. IV (Jul.-Aug. 2018), PP 59-66 www.iosrjournals.org Comparison of socio-demographic and
More informationSchizophrenia: Treating The Whole Person
Schizophrenia: Treating The Whole Person Jacob S. Ballon, M.D., M.P.H & Douglas L. Noordsy, M.D. INSPIRE Clinic PEPPNET Prodrome and Early Psychosis Program NETwork Stanford University Department of Psychiatry
More informationIn recent years, reports of diabetes, diabetic
A REVIEW OF METABOLIC ISSUES IN ATYPICAL ANTIPSYCHOTIC TREATMENT John W. Newcomer, MD, * and Henry A. Nasrallah, MD ABSTRACT Reports of diabetes, diabetic ketoacidosis, hyperglycemia, and dyslipidemias
More informationKetogenic Diets-good, bad, indifferent? Peter Clifton CSIRO Human Nutrition
Ketogenic Diets-good, bad, indifferent? Peter Clifton CSIRO Human Nutrition Presenter Disclosure Information
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response
More informationBariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes
The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,
More informationEfficacy and safety of brexpiprazole for the treatment of acute. schizophrenia: a 6-week, randomized, double-blind, placebocontrolled
Supplementary material Efficacy and safety of brexpiprazole for the treatment of acute schizophrenia: a 6-week, randomized, double-blind, placebocontrolled trial Christoph U. Correll, M.D. 1, Aleksandar
More informationCoach on Call. Please give me a call if you have more questions about this or other topics.
Coach on Call It was great to talk with you. Thank you for your interest in. I hope you find this tip sheet helpful. Please give me a call if you have more questions about this or other topics. As your
More informationTest5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight
Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight Quest, Quest Diagnostics, the associated logo, and all associated Quest Diagnostics marks are the registered trademarks of Quest
More informationFructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism
Fructose in diabetes: Friend or Foe Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism Contents What is Fructose? Why is Fructose of Concern? Effects of Fructose on glycemic
More informationHelpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center
Helpful Hints for Taking Care of Your Diabetes Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center Objectives How big of a problem is diabetes? What is diabetes? How is
More informationThe Potential for High-Intensity Interval Training to Reduce Cardiometabolic Disease Risk
REVIEW ARTICLE Sports Med 2012; 42 (6): 489-509 0112-1642/12/0006-0489/$49.95/0 Adis ª 2012 Springer International Publishing AG. All rights reserved. The Potential for High-Intensity Interval Training
More informationTransdermal Cannabidiol (CBD) Gel for the Treatment of Fragile X Syndrome (FXS)
Transdermal Cannabidiol (CBD) Gel for the Treatment of Fragile X Syndrome (FXS) H. Heussler, MD; J. Cohen, MD; N. Silove, MD; N. Tich, PhD; C. O Neill; and M. Bonn-Miller, PhD Liza A. Squires, MD Chief
More informationMetabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics
Metabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationSITA 100 mg (n = 378)
Supplementary Table 1. Summary of Sulfonylurea Background Therapy at Baseline and During the Treatment Period. Sulfonylurea at baseline, n (%) SITA 100 mg (n = 378) CANA 300 mg (n = 377) Total (N = 755)
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationMedications in Autism: What We Know and Don't Know
Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
More informationSupplementary Online Content
Supplementary Online Content Hudson JI, McElroy SL, Ferreira-Cornwell MC, Radewonuk J, Gasior M. Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: a randomized clinical
More informationSupplementary Online Content
Supplementary Online Content Lam RW, Levitt AJ, Levitan RD, et al. Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized
More informationSupplemental Table 1 Age and gender-specific cut-points used for MHO.
Supplemental Table 1 Age and gender-specific cut-points used for MHO. Age SBP (mmhg) DBP (mmhg) HDL-C (mmol/l) TG (mmol/l) FG (mmol/l) Boys 6-11 90th * 90th * 1.03 1.24 5.6 12 121 76 1.13 1.44 5.6 13 123
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationSupplementary Online Content 2
Supplementary Online Content 2 Bieleninik Ł, Geretsegger M, Mössler K, et al; TIME-A Study Team. Effects of improvisational music therapy vs enhanced standard care on symptom severity among children with
More informationA study to find out the relationship between insulin resistance and hypertension
International Journal of Advances in Medicine http://www.ijmedicine.com pissn 49-95 eissn 49-9 Original Research Article DOI: http://dx.doi.org/.10/49-9.ijam01771 A study to find out the relationship between
More information5g vs. control, contrast. 10g vs. control, contrast. -3.6e-15 ± 4.3
Supplementary Materials: A Double-Blind, Randomized Controlled, Acute Feeding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Blood Glucose Metabolism in Healthy Participants:
More informationTesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies
Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Copyright 2016. All Rights Reserved. Property of Theratechnologies Inc. Mechanism of Action of Tesamorelin
More information